Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px
All > Germany >

Deals > Southern Germany

Find below deals from the Southhern German Federal States of Baden-Württemberg and Bayern (Bavaria). Listed are deals for this region as well as from organisations located there.

Total search results: 1312 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Affimed–JPMorgan Chase: investor conference, 201901 supply service Affimed presents at JP Morgan Healthcare Conference 2019 2019-01-10
Medigene–Helmholtz: cell therapy, 201901– license to co-stimulator to enhance TCR therapies for solid tumours from HMGU 2019-01-04
Atriva Therapeutics–High-Tech Gründerfonds: investment, 201901 financing round Series A first closing led by Meneldor + HTGF 2019-01-03
Atriva Therapeutics–MC Services: public relations, 201901 service existent by MC Services 2019-01-03
Atriva Therapeutics–Meneldor: investment, 201901 financing round Series A first closing led by Meneldor + HTGF 2019-01-03
Atriva Therapeutics–SEVERAL: investment, 201901 financing round Series A first closing led by Meneldor + HTGF 2019-01-03
Evitria–SHS: investment, 201812 acquisition majority stake by Afinum Achte Beteiligungs GmbH & Co KG + SHS V Medtech Investments GmbH 2018-12-20
PreOmics–High-Tech Gründerfonds: investment, 201812 financing round Series A totalling €3.3m incl HTGF + Think.Health Ventures + business angels 2018-12-18
PreOmics–SEVERAL: investment, 201812 financing round Series A €3.3m from HTGF + Think.Health Ventures + business angels 2018-12-18
PreOmics–Think.Health Ventures: investment, 201812 financing round Series A totalling €3.3m incl HTGF + Think.Health Ventures + business angels 2018-12-18
Orchard Therapeutics–Sirion Biotech: gene therapy manufacturing technology, 201812– license for stem cell gene therapies 2018-12-14
AC Immune–Hopp Group: investment, 201812 existent investment dievini Hopp owns 27% of AC Immune SA 2018-12-05
Apogenix–Hopp Group: investment, 201812 existent investment dievini Hopp owns 92% of Apogenix AG 2018-12-05
Cassiopea–Hopp Group: investment, 201812 existent investment dievini Hopp owns 1% of Cassiopea SpA 2018-12-05
Cosmo Pharmaceuticals–Hopp Group: investment, 201812 existent investment dievini Hopp owns 5% of Cosmo SpA 2018-12-05
CureVac–Hopp Group: investment, 201812 existent investment dievini Hopp owns 80% of CureVac AG 2018-12-05
Heidelberg Pharma–Hopp Group: investment, 201812 existent investment dievini Hopp owns 83% of Heidelberg Pharma AG 2018-12-05
Immatics–Hopp Group: investment, 201812 existent investment dievini Hopp owns 38% of Immatics GmbH 2018-12-05
Joimax–Hopp Group: investment, 201812 existent investment dievini Hopp owns 85% of Joimax GmbH 2018-12-05
Molecular Health–Hopp Group: investment, 201812 existent investment dievini Hopp owns 95% of Molecular Health GmbH 2018-12-05
Novaliq–Hopp Group: investment, 201812 existent investment dievini Hopp owns 93% of Novaliq GmbH 2018-12-05
SpinDiag–SEVERAL: investment, 201811 financing round Series A €3m 2018-11-27
Adrenomed–MC Services: public relations, 201811 service existent by MC Services 2018-11-26
Adrenomed–Wellington Partners: investment, 201811 financing round Series D totalling €24m incl new + co-lead investor Wellington Partners 2018-11-26
Quarton International–Cowen: investment, 201811–201901 acquisition of Quarton by Cowen 2018-11-20
I-Mab–MorphoSys: antibody cancer drug, 201811– license excl Greater China + KR for MOR210 with $3.5m upfront + $101.5m milestones + royalties 2018-11-15
Omeicos–Forbion: investment, 201811 financing round Series C totalling €17m incl new + lead investor Forbion 2018-11-02
HBM–CMS: legal services, 201811 supply service legal advice by CMS for both lead investors HBM + Wellington of Adrenomed Series D round 2018-11-01
Wellington Partners–CMS: legal services, 201811 supply service legal advice by CMS for both lead investors HBM + Wellington of Adrenomed Series D 2018-11-01
Quantum Analytics–Bruker Corp: analytical instruments, 201810– distribution of S2 Puma + S2 Polar + D2 Phaser analysers in the US by Quantum Analytics 2018-10-16
Gotham Therapeutics–MacDougall Biomedical Communications: public relations, 201810 service existent by MacDougall 2018-10-10
Sphingotec–Wellington Partners: investment, 201810 financing round totalling €20m incl co-lead investor Wellington Partners 2018-10-08
B Braun–CeGaT: personalised medicine, 201810 collab establishment JV to develop personalised cancer vaccines CeCaVa GmbH & Co KG 2018-10-01
Helmholtz–Bruker Corp: MRI system, 201810 supply 9.4 Tesla preclinical MRI system with integrated PET detector to DKFZ 2018-10-01
Evotec–Berenberg: investor conference, 201809 supply service Evotec attends 7th German Corporate Conference in Munich 2018-09-26
Evotec–Baader Bank: investor conference, 201809 supply service Evotec attends Baader Investment Conference 2018 in Munich 2018-09-24
Plug and Play–Roche: healthcare, 201809–202108 collab creation of Startup Creasphere innovation program in Munich with Roche Diagnostics 2018-09-20
Merck (DE)–AstraZeneca: digital pathology, 201809– collab multi-year partnership with Definiens using TissuePhenomics for biomarker quantification 2018-09-10
RSP Systems–Trumpf: investment, 201809 financing round Series B 2nd closing totalling €3.85m incl new investor Trumpf Venture GmbH 2018-09-10
Affimed–Wells Fargo: investor conference, 201809 supply service Affimed presents at Wells Fargo Healthcare Conference in Boston 2018-09-06
Roche–Affimed: antibody cancer drug, 201808– collab $96m ufpront + $5b milestones + royalties using ROCK platform to develop ABs with Genentech 2018-08-27
Hain Lifescience–Bruker Corp: investment, 201808– acquisition €na of 80% majority interest with option to acquire rest in 2012 ANNOUNCED 2018-08-24
Univ Warwick–Bruker Corp: NMR spectrometer, 201808 supply Avance 1.0 GHz solid-state NMR spectrometer 2018-08-06
Biocrates–MC Services: public relations, 201807 service existent by MC Services 2018-07-25
SHS–SEVERAL: investment, 201807 first closing €90m of SHS V fund with target size of €150m 2018-07-20
Novartis–MorphoSys: therapeutic antibody, 201807– license excl ww to MOR106 from MOR+GLPG €95m upfront + €850m milestones + royalties + funding 2018-07-19
Adocia–MC Services: public relations, 201807 service existent PR Europe by MC Services 2018-07-18
B Braun–CeGaT: personalised medicine, 201807 collab establishment of B Braun Precision Medicine Technology (Shanghai) Ltd 2018-07-17
CeGaT–B Braun: investment, 201807 existent 30% shareholding of B Braun in CeGaT 2018-07-17
Polares Medical–Wellington Partners: investment, 201807 financing round totalling $25m incl co-investor Wellington Partners 2018-07-17
Genmab–Immatics: cancer immunotherapy, 201807– researc collab + excl license to targets for biospecific I-O drugs $54m upfront + $550m milestones 2018-07-12
BioNTech–Trophic Communications: public relations, 201807 service existent German media relations by Trophic 2018-07-10
IMMUNOMONITOR project–Biomax: pharmacogenomics, 201807– collab partner in Eurostars project to develop validation treatm response to cancer vaccines 2018-07-05
Curetis–Goetzpartners: investor conference, 201806 supply service Curetis presents at Goetzpartners Healhlcare Day 2018 in London 2018-06-22
Sartorius–Siemens: automation technology, 201806– collab long-term using Siemens automation for SSB’s bio production offerings 2018-06-12
Treeway–Trophic Communications: public relations, 201805 service existent by Trophic 2018-05-29
Medigene–SEVERAL: investment, 201805 private placement €32.3m 2.23m new shares at €14.5/share to institutional investors 2018-05-24
Lava Therapeutics–Trophic Communications: public relations, 201805 service existent by Trophic 2018-05-23
Acousia Therapeutics–Boehringer: investment, 201805 financing round Series B totalling €10m incl existing + co-investor BIVF 2018-05-14
Acousia Therapeutics–Bregua Corp: investment, 201805 financing round Series B totalling €10m incl new + co-investor Bregua Corp 2018-05-14
Acousia Therapeutics–Creathor Venture: investment, 201805 financing round Series B totalling €10m incl new + co-investor Creathor Venture 2018-05-14
Acousia Therapeutics–Germany (govt): investment, 201805 financing round Series B totalling €10m incl existing + co-investor KfW 2018-05-14
Acousia Therapeutics–Instinctif Partners: public relations, 201805 service existent by Instinctif 2018-05-14
Acousia Therapeutics–LBBW: investment, 201805 financing round Series B totalling €10m incl lead + new investor LBBW Venture Capital 2018-05-14
Acousia Therapeutics–SEVERAL: investment, 201805 financing round Series B €10m led by new investor LBBW Venture Capital 2018-05-14
Bluebird Bio–Medigene: TCR technology, 201805– collab strategic alliance expansion incl $8m one-time payment 2018-05-14
AdvanceCor–SEVERAL: investment, 201805 financing round €6m led by MIG AG + incl Occident Group + Bayern Kapital + HTGF + KfW Bank + founders 2018-05-01
Bosch–Randox: point-of-care diagnostics, –201804 collab developm test panels for Vivalytic POC analyser 2018-04-21
Novartis–Pear Therapeutics: digital health, 201804– collab developm + commercialisation of prescripition digital therapeutics for drug abuse Sandoz 2018-04-18
DKSH–Bruker Corp: analytical instruments, 201804– distribution multi-product line of Bruker AXS in KR + AU + NZ + SG + ID by DKSH Technology 2018-04-17
Boehringer–Biomax: bioinformatics, 201804– license multi-year for BioXM s/w + license extension for BioRS s/w 2018-04-10
Promethera–MacDougall Biomedical Communications: public relations, 201804 service existent by MacDougall 2018-04-10
Allecra Therapeutics–HC Wainwright: investor conference, 201804 supply service Allecra presents at HC Wainwright Global Life Sciences Conference 2018-04-08
Medigene–Needham: investor conference, 201803 supply service Medigene presents at Annual Needham Healthcare Conference in NY 2018-03-27
MorphoSys–SEVERAL: investment, 201803–201804 US IPO $208m+$31m with 8.3m+1.245m ADSs at $25.04/ADS + listing at Nasdaq Global Market 2018-03-22
Robert Bosch Hospital–bio.logis: genetic software, 201803– supply implementation of bio.logis GIMS IT platform at RBK 2018-03-20
Bruker Corp–KAUST: magnet resonance technology, 201803– collab establ KAUST-Bruker Center of Excellence in Magnetic Resonance 2018-03-18
KAUST–Bruker Corp: magnetic resonance technology, 201803 supply 500 MHz super wide-bore MRI spectrometer at KAUST-Bruker CoE in Magnetic Resonance 2018-03-18
KAUST–Bruker Corp: magnetic resonance technology, 201803 supply 900 MHz wide-bore NMR spectrometer at KAUST-Bruker CoE in Magnetic Resonance 2018-03-18
KAUST–Bruker Corp: magnetic resonance technology, 201803 supply 950 MHz NMR spectrometer at KAUST-Bruker CoE in Magnetic Resonance 2018-03-18
KAUST–Bruker Corp: magnetic resonance technology, 201803 supply DNP NMR spectrometer at KAUST-Bruker CoE in Magnetic Resonance 2018-03-18
Siemens–SEVERAL: investment, 201803 IPO €4.2b of Siemens Healthineers AG at FSE floating 150m (15% of) shares at €28/share 2018-03-16
Medigene–Informa: partnering conference, 201803 supply service Medigene participates in BIO-Europe Spring 2018 2018-03-12
Medigene–Roth Capital Partners: investor conference, 201803 supply service Medigene presents at Annual Roth Conference 2018 2018-03-11
Magenta Therapeutics–Heidelberg Pharma: antibody-drug conjugates, 201803– collab developm of ADCs for bone marrow transplant using ATAC platform 2018-03-05
Heidelberg Pharma–MC Services: public relations, 201803 service existent by MC Services 2018-03-01
Heidelberg Pharma–Univ Texas: personalised medicine, 201803– license for Dx + Tx of cancer patients w RNA polymerase II deletion 2018-03-01
IRM² Infrarot Mikroskopie und Messtechnik GmbH–Bruker Corp: investment, 201802 acquisition €na of IRM² by Bruker 2018-02-22
Cullinan Oncology–MAB Discovery: antibody cancer drug, 201802– collab developm of MAbs based on MAB Discovery’s discovery platform 2018-02-20
Affimed–SEVERAL: investment, 201802 public offering $26.5m ($24.5m net) with 12.5m+1.725m common shares at $2/share 2018-02-12
Pieris–Trophic Communications: public relations, 201802 service existent media relations by Trophic 2018-02-09
4SC–Life Sciences Partners: investor conference, 201802 supply service 4SC AG presents at BioCapital Europe 2018 2018-02-06
Medigene–Life Sciences Partners: investor conference, 201802 supply service Medigene AG presents at BioCapital Europe 2018 2018-02-06
Faron Pharmaceuticals–Rentschler: Traumakine, 201802 supply existent contract manfucturing by Rentschler Biopharma SE 2018-02-05
Cytosurge–Lab Automation Network: cell analysis technology, 201802– collab product integration to offer automated single-cell biology applications 2018-02-01
Immunicum–Trophic Communications: public relations, 201801 service existent IR + media relations EU + US by Trophic 2018-01-31
Novartis–Biocon: biosimilars, 201801– collab strategic ww excl developm + production + comercialisation Sandoz + Biocon 2018-01-18
Eximmium–Helmholtz: investment, 201801 seed funding €250k from Helmholtz Enterprise + Helmholtz Zentrum München at spin off of Eximmium 2018-01-17
Sartorius–Synpromics: genomic technology, 201801 collab existent with Sartorius Stedim Cellca 2018-01-17
CureVac–JPMorgan Chase: investor conference, 201801 supply service CureVac presents at JP Morgan Healthcare Conference 2018 2018-01-08
1 2 3 4 5 6 7 8 9 10 11 12 13 14  next pagenext page



Advertisement

Picture [iito] – Putting Information into Context 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top